Niagen Bioscience Inc (NAGE) key performance indicators and operating metrics (5 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Gross Margin Percentage | 63.50 percent | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 3.8M | FY2026-Q1 |
| Tru Niagen Net Sales | 22.4M | FY2026-Q1 |
| Selling and Marketing Expense as a Percentage of Net Sales | 25.80 percent | FY2025-Q3 |
| Niagen Ingredient Net Sales | 7.4M | FY2025-Q2 |
Back to NAGE overview · NAGE earnings · NAGE holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.